Skip to Content

The giant Euro sign in front of the European Central Bank in Frankfurt am Main, Germany. Photo credit: Mika Baumeister
Paris

EU bought 500 000 doses of ineffective drug for €1 970 per unit

The contract was signed in early October related to doses of Remdesivir, even though the WHO had not issued its conclusions concerning it. Once again, is this the sign of an unpreparedness or Big Pharma lobbies operating within Europe?

Published: December 30, 2020, 1:07 pm

    Read more

    According to information from our French colleagues at le Canard Enchaîné, the European Commission signed a huge contract concerning the drug from the American company Gilead, known as Remdesivir.

    The agreement was inked on October 7, supposedly to fight against Covid-19. However, on the one hand, no study had been done on the effectiveness of this drug, but above all, a body of the WHO (World Health Organization) had not yet delivered its conclusions. Worse still, the amount paid by Europe is astronomical according to the French newspaper, since each dose was purchased at the price of… 1 970 euros!

    And because calamities always happen in a series, barely a week after signing the contract, the body responsible for monitoring the effectiveness of the drug delivered its verdict: “Remdesivir seems to have little or no effects on hospitalized patients.” An EC source later said he was not aware of the existence of the study.

    This ignorance is peculiar, according to the Canard, because European representatives meet WHO emissaries in Brussels every week. In addition, despite numerous meetings, the ongoing study of Gilead’s drug was never mentioned. Also, in August, the European Health Security Committee had mentioned the use of Remdesivir, reaffirmed it in September, twice, then in October too before the signing of the contract without informing the WHO representative.

    However, according to our colleagues, the WHO had already known about the unsatisfactory results since September 23, results that the organization transmitted to the laboratory but not to Europe. As an excuse, the WHO claimed that it acted only “as an observer”.

    The contract did not bear “any mention of an obligation to purchase” but many countries still paid for the doses, except France which had already judged it to be ineffective earlier.

    According to two German media outlets, France has also delayed the purchase of vaccinations to favor Sanofi in the European Union even though the French company’s vaccine will not be ready before the end of 2021.

    This information must taken with a grain of salt, but according to the “serious” mainstream German newspapers Der Spiegel and Die Zeit, the European Union has been offered 500 million (as well as an additional 100 million) doses of the vaccine from the company BioNTech, the German partner of the American firm Pfizer. But the offer was rejected, allegedly to help Sanofi.

    According to the Brussel Times, the French government opposed this new offer because the contract had changed to more than 800 million doses. Interestingly, the vaccine from Pfizer/BioNTech has been valued at around twelve euros, against only €7,50 for that of Sanofi. The costs had been confidential until a Belgian official tweeted — and then deleted — the price list.

    The European Union declined to respond to the revelations by Der Spiegel.

    In France, the first vaccinations against Covid-19 are due to start in January. And big reinforcements will be deployed to monitor potential side effects related to vaccines, FranceInfo reported. The whole population will be targeted and surveyed.

    Thus mass surveillance, cloaked as “pharmacovigilance” will have to meet several challenges in 2021: specifying the efficacy and risks of vaccines and responding to the fears of the French, who are very suspicious of vaccination. The first vaccines that will be available in January in France were developed in record time, and are therefore subject to doubts in terms of safety and efficacy.

    To overcome them, vaccine surveillance systems will be strengthened, said the National Agency for the Safety of Medicines and Health Products (ANSM). It will be necessary “to identify the possible undesirable effects which would not have been observed during the clinical trials”.

    But the equation is complex: Six vaccine candidates have been pre-ordered for the European Union, with four different technologies used and a vaccination schedule which still has to be defined.

    Candidates for Covid-19 vaccines will go through the sieve of the Committee for Medicinal Products for Human Use (CHMP), just like their predecessors, assured the European Medicines Agency (EMA), in charge of the attribution of marketing.

    Once the valuable marketing authorizations (AMM) have been issued, a new phase of evaluation of these vaccines will begin. On the one hand through the pursuit of longer-term industrial and academic studies (phase 4) of people who have been involved in phase 3 clinical trials. But above all, “in real life”. The vaccines will be injected into several hundred thousand people, which will make it possible to trace any adverse effects not observed during the previous stages, they maintain.

    “The clinical trials are adapted to the evaluation of the benefit but remain insufficient for the study of the drug risk since they include too few patients, are too short or too often exclude the subjects at risk,” explained the Regional Center of Pharmacovigilance from Toulouse.

    “Only post-marketing follow-up makes it possible to clearly specify the undesirable effects and therefore the benefit/risk ratio of the drug.” Clearly, citizens are being used as the proverbial guinea pigs.

    The United Kingdom began its vaccination campaign on December 7. “When we begin to vaccinate in France, the English will already have vaccinated over a million people,  said Bégaud Bernard,  professor of pharmacology at ANSM. “That will be very valuable, because we will thus have a hindsight of at least a month on a mass vaccination.”

    A large platform, called SI-Vaccination, will monitor the massive roll-out. It was designed to help general practitioners, who asked for the installation of a tool allowing them to forward a maximum of information on the vaccination, while organizing the follow-up of the patients concerned.

    Additional technical and human resources should make it possible to cope with this unprecedented vaccination campaign, announced the ANSM. An artificial intelligence module will in particular be made available to the centers to facilitate the classification of declarations.

    Consider donating to support our work

    Help us to produce more articles like this. FreeWestMedia is depending on donations from our readers to keep going. With your help, we expose the mainstream fake news agenda.

    Keep ​your language polite​. Readers from many different countries visit and contribute to Free West Media and we must therefore obey the rules in​,​ for example​, ​Germany. Illegal content will be deleted.

    If you have been approved to post comments without preview from FWM, you are responsible for violation​s​ of​ any​ law. This means that FWM may be forced to cooperate with authorities in a possible crime investigation.

    If your comments are subject to preview ​by FWM, please be patient. We continually review comments but depending on the time of day it can take up to several hours before your comment is reviewed.

    We reserve the right to del​ete​ comments that are offensive, contain slander or foul language, or are irrelevant to the discussion.

    Europe

    Armin Laschet to lead Angela Merkel’s CDU as new chairman

    The Minister President of North Rhine-Westphalia, the most populous of the 16 states of Germany, Armin Laschet was elected as the new CDU chairman at the digital CDU party conference on Saturday. In the runoff election he prevailed with 521 votes against his toughest competitor Friedrich Merz (466 votes). In a nutshell, the party establishment pushed through its candidate, while the voter's candidate failed.

    The new rise of ISIS in Syria: The reasons and possible consequences

    Deir EzzorThe Syrian province of Deir Ezzor is back in the news after Israel's devastating airstrikes on Syria. However, against this background, most of the Western media has overlooked other events that may prove to be far more important to the security of both the Middle East and Europe.

    Italy: A poll that could become a nightmare for the left

    RomeBad news for the Democratic Party in Italy, which has seen Giorgia Meloni's party dangerously approaching them in the polls. Fratelli d'Italia (FdI) seems to be making great strides towards becoming the second largest party in the country after the Lega led by Matteo Salvini.

    Violent crime rises dramatically in French countryside new data reveals

    ParisA particularly worrying assessment of crime in the French countryside has seen the light. Crime is on the rise almost everywhere in France according to the 2020 report from the SSMI - Statistical Service of the French Ministry of the Interior .

    Islamist currents in France desperate to hinder ‘Charter of Values’

    ParisThe numbers are overwhelming, and so are the testimonials. Data collected by French pollster Ifop for the Jaurès Foundation, which had interviewed several teachers confronted with political Islam even in their classes, paint a dreary picture.

    The Hungarian social network to counter Facebook: ‘Hundub’

    BudapestIts designers promise a social network "without censorship" while its detractors see in it a political maneuver by Hungarian Prime Minister Viktor Orban.

    Significant numbers of German nursing staff refusing Covid-19 vaccine

    For a large number of old people in nursing homes, a Corona vaccination is likely to be given a little earlier than expected. That is because about half of the nursing staff in Germany have decided to forego the "privilege" of being vaccinated against Corona first.

    The fire in the Lipa migrant camp

    The Bosnian "refugee" camp near Lipa burned down on December 23, 2020. The timing is suspicious since one inevitably thinks of Moria and the consequences. What better way to soften European hearts shortly before Christmas Eve in order to achieve a similar effect? However, the Lipa case has some deviations from Moria, but none of them can really be explained.

    Urban violence ushers in New Year in France, Germany

    ParisIn 2021, scenes of urban violence were witnessed throughout France despite the Corona curfew. There were 662 arrests, with 25 police officers and gendarmes injured.

    Vaccinated on Christmas Eve, dead five days later

    LucerneA person died in Switzerland five days after receiving the SARS-CoV-2 vaccine. Authorities said a link with the vaccine was "highly unlikely". German media called his doctor a "Coronavirus skeptic".

    Go to archive